Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasms × Gels × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 11 Head and Neck Neoplasms 3 Condylomata Acuminata 3 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Exanthema 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Wounds and Injuries 1 Warts 1 Virus Diseases 1 Usual Type Vulval Intraepithelial Neoplasia (uVIN) 1 Squamous Intraepithelial Lesions 1 Skin Neoplasms 1 Sexually Transmitted Diseases 1 Radiodermatitis 1 Parapsoriasis 1 Papillomavirus Infections 1 Neoplasms 1 Keratosis, Seborrheic 1 Hypogonadism 1 Hemangioma, Cavernous 1 Hemangioma 1 Fatigue 1 Eunuchism 1 Dermatitis, Contact 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Cancer Pain 1 Breast Carcinoma In Situ 1

Interventions

pembrolizumab 146 Gemcitabine 134 Paclitaxel 126 Carboplatin 116 Bevacizumab 108 Docetaxel 94 Cyclophosphamide 93 Cisplatin 92 Exercise 78 Nivolumab 77 Fluorouracil 73 Capecitabine 72 Dexamethasone 70 Irinotecan 62 Radiotherapy 57 Pemetrexed 57 Oxaliplatin 57 Standard of Care 55 Leucovorin 53 Cetuximab 47 Drug Therapy 45 Sorafenib 44 Erlotinib Hydrochloride 44 Doxorubicin 41 atezolizumab 40 Blood Specimen Collection 40 130-nm albumin-bound paclitaxel 37 trametinib 34 Ipilimumab 34 venetoclax 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04301765 2025-03-11

TEMEC

Seattle Institute for Biomedical and Clinical Research

Phase 2 Recruiting

Eunuchism, Fatigue, Hypogonadism, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡